Cancer-specific nanoparticle mediated DNA delivery to human hepatocellular carcinoma using synthetic poly(BETA-amino ester) vectors

Purpose: To evaluate a single institutional experience with minimally invasive limited ligation endoluminal-assisted revision (MILLER) for treatment of dialysis access steal syndrome (DASS). Materials and Methods: Thirty-three patients (20 men and 13 women; average age 64.4 14.8 years) were retrospectively identified that underwent 46 MILLER procedures for dialysis access steal syndrome and high-output heart failure at our institution from March 2010 to September 2013. Technical success was defined by successful creation of MILLER band without complications. Clinical success was defined as no repeat interventions for 1 month after the initial banding procedure. Results: Technical success was achieved in all patients. Clinical success was reached in 91%. Primary patency rates of MILLER bands created in this study were 91% at 1 month and 76% at 6 months. Conclusion: MILLER banding is a suitable alternative for treatment of DASS.